Lexeo Therapeutics (LXEO) Change in Acquisitions & Divestments (2025 - 2026)

Lexeo Therapeutics (LXEO) has 2 years of Change in Acquisitions & Divestments data on file, last reported at $27.5 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Acquisitions & Divestments rose 76.25% year-over-year to $27.5 million; the trailing twelve-month figure through Mar 2026 stood at $117.4 million (changed N/A YoY), and the FY2025 full-year result was $105.5 million, changed N/A from the prior year.
• Change in Acquisitions & Divestments declined to $27.5 million in Q1 2026, from $38.3 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $38.3 million in Q4 2025 to a low of $15.6 million in Q1 2025.